Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Catur Sentosa Adiprana Tbk. (CSAP) vs Hetzer Medical Indonesia Tbk. (MEDS) Price & Performance

Catur Sentosa Adiprana Tbk.Trade
Hetzer Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Catur Sentosa Adiprana Tbk. vs Hetzer Medical Indonesia Tbk. — how do they compare? Catur Sentosa Adiprana Tbk. trades at Rp304 (market cap 1.67T, 1.28M 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp73 (market cap 109.38B, 60.43M 24h volume). The key difference: Catur Sentosa Adiprana Tbk. is far larger — about 15.3× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (60.43M versus 1.28M). Which is the better fit depends on your goals.

CSAPMEDS
Market Cap
1.67T109.38B
Volume
1.28M60.43M
Lot
12.81K604.35K
Turnover
380.73M4.46B
Average Price
297.1973.8
Value
380.73M4.46B
Indicative Equilibrium Price
30473
Indicative Equilibrium Volume
2112.68K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CSAP
View details
MEDS
View details

About Catur Sentosa Adiprana Tbk.

Catur Sentosa Adiprana Tbk (the company) was established on 31 Dec 1983 based on Notaries Deed No. 93 and the deed of establishment was approved by the the Ministry of Justice dated Sep 18, 1983. Based on the Company’s stockholders’ circular resolution dated June 6, 2007, the stockholders approved the change in the legal status of the Company from a Limited Liability Company “Perseroan Terbatas” with Foreign Capital Investments facility to a Limited Liability Company “Perseroan Terbatas” with Non-Foreign Capital Investments facility/Domestic Capital Investments, including the revocation and/or cancellation of every existing agreement of the Company related to Foreign Capital Investments.

Read more on CSAP

About Hetzer Medical Indonesia Tbk.

PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.

Read more on MEDS